Gradalis, Inc.
PrivateLast Round
Grant
Nov 15, 2023
Total Funding Raised
$77.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gradalis, Inc. is a biotechnology company that develops and commercializes novel personalized therapeutics to treat cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gradalis, Inc. Comparables
Compare Gradalis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gritstone bio | 78% | |
| PhotonPharma | 78% | |
| Imunon Inc | 77% |
Gradalis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 15, 2023 | ||||
| Series C | Apr 2, 2018 | ||||
| Series B | Jan 3, 2013 |
Gradalis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 47% MoM.
- Nov 9, 2025
Monthly visitors increased 183% MoM, reaching 518.
Gradalis, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gradalis, Inc.'s valuation, stock price, and market status.
Is Gradalis, Inc. a public or private company?
Gradalis, Inc. is a private company.
What is the current stock price of Gradalis, Inc.?
Gradalis, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Gradalis, Inc. worth (valuation)?
Valuation information for Gradalis, Inc. is not publicly available.
Can I buy Gradalis, Inc. stock?
Gradalis, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gradalis, Inc.'s last funding round?
Gradalis, Inc.'s most recent funding round was Grant on November 15, 2023.
Who are the main investors in Gradalis, Inc.?
Key investors in Gradalis, Inc. include Cancer Prevention and Research Institute of Texas.
Will Gradalis, Inc. IPO soon?
No public IPO plans have been announced for Gradalis, Inc..
How can I track Gradalis, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gradalis, Inc.'s secondary market activity and sign up for updates.